CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-31 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −2,678 | $70.54 | $189K | 239,678 |
| 2019-03-31 | CAREY STEPHEN P. Vice President and CFO | Shares withheld for taxes | −507 | $70.54 | $36K | 26,062 |
| 2019-03-28 | Walsh Patrick D Director | Grant or award | +1,991 | 3,791 | ||
| 2019-03-28 | Walsh Patrick D Director | Grant or award · Stock Options | +2,409 | 2,409 | ||
| 2019-03-28 | NASH DAVID Director | Grant or award | +1,991 | 3,791 | ||
| 2019-03-28 | NASH DAVID Director | Grant or award · Stock Options | +2,409 | 2,409 | ||
| 2019-03-28 | Marken James G. SVP Ops & Prod Dev | Grant or award | +6,848 | 75,928 | ||
| 2019-03-28 | Marken James G. SVP Ops & Prod Dev | Grant or award · Stock Options | +8,285 | 8,285 | ||
| 2019-03-28 | PRZYBYL ARTHUR President and CEO | Grant or award | +37,280 | 242,356 | ||
| 2019-03-28 | PRZYBYL ARTHUR President and CEO | Grant or award · Stock Options | +45,106 | 45,106 | ||
| 2019-03-28 | CAREY STEPHEN P. Vice President and CFO | Grant or award | +12,451 | 26,569 | ||
| 2019-03-28 | CAREY STEPHEN P. Vice President and CFO | Grant or award · Stock Options | +15,064 | 15,064 | ||
| 2019-03-28 | HAUGHEY THOMAS Director | Grant or award | +1,991 | 3,791 | ||
| 2019-03-28 | HAUGHEY THOMAS Director | Grant or award · Stock Options | +2,409 | 2,409 | ||
| 2019-03-28 | Brown Robert E. JR Director | Grant or award | +2,584 | 20,352 | ||
| 2019-03-28 | Brown Robert E. JR Director | Grant or award · Stock Options | +3,127 | 3,127 | ||
| 2019-03-28 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Grant or award | +12,451 | 60,293 | ||
| 2019-03-28 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Grant or award · Stock Options | +15,064 | 15,064 | ||
| 2019-03-28 | Penn Thomas A. Director | Grant or award | +1,991 | 14,301 | ||
| 2019-03-28 | Penn Thomas A. Director | Grant or award · Stock Options | +2,409 | 2,409 |
Page 29 of 31 · 601 trades